Pages that link to "Q73642418"
Jump to navigation
Jump to search
The following pages link to Inhibition of human lung cancer cell growth by the peroxisome proliferator-activated receptor-gamma agonists through induction of apoptosis (Q73642418):
Displaying 50 items.
- The Role of PPARs in Cancer (Q21342955) (← links)
- Prostacyclin inhibits non-small cell lung cancer growth by a frizzled 9-dependent pathway that is blocked by secreted frizzled-related protein 1 (Q24303556) (← links)
- (Q24806395) (← links)
- The pathophysiological function of peroxisome proliferator-activated receptor-gamma in lung-related diseases. (Q24814517) (← links)
- PPARγ as a Novel Therapeutic Target in Lung Cancer (Q28068114) (← links)
- Activation of peroxisome proliferator-activated receptor-gamma stimulates the growth arrest and DNA-damage inducible 153 gene in non-small cell lung carcinoma cells (Q28214426) (← links)
- Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists (Q28269915) (← links)
- Inhibition of peroxisome-proliferator-activated receptor (PPAR)alpha by MK886 (Q28366307) (← links)
- Peroxisome proliferator-activated receptor gamma ligand-induced growth inhibition of human hepatocellular carcinoma (Q28366616) (← links)
- Minireview: Familiar Faces in Unfamiliar Places: The Emerging Role of Nuclear Receptors in Lung Cancer (Q33631471) (← links)
- In vivo effects of rosiglitazone in a human neuroblastoma xenograft (Q33723620) (← links)
- The anti-tumorigenic properties of peroxisomal proliferator-activated receptor alpha are arachidonic acid epoxygenase-mediated (Q33800226) (← links)
- Bioinformatics analyses of the differences between lung adenocarcinoma and squamous cell carcinoma using The Cancer Genome Atlas expression data (Q33828083) (← links)
- Enhancement of docetaxel anticancer activity by a novel diindolylmethane compound in human non-small cell lung cancer (Q33837550) (← links)
- Transforming growth factor beta1 enhances tumor promotion in mouse skin carcinogenesis (Q33884576) (← links)
- Prostaglandin (PG)D(2) and 15-deoxy-Delta(12,14)-PGJ(2), but not PGE(2), mediate shear-induced chondrocyte apoptosis via protein kinase A-dependent regulation of polo-like kinases (Q33926052) (← links)
- Interleukin-6 synthesis in human chondrocytes is regulated via the antagonistic actions of prostaglandin (PG)E2 and 15-deoxy-Δ(12,14)-PGJ2. (Q34077992) (← links)
- Telmisartan inhibits human urological cancer cell growth through early apoptosis (Q34418476) (← links)
- Caspase 2 activation and ER stress drive rapid Jurkat cell apoptosis by clofibrate (Q34428761) (← links)
- Peroxisome proliferator-activated receptor gamma (PPARgamma) and its ligands: a review (Q34568687) (← links)
- Nonsteroidal anti-inflammatory drugs, apoptosis, and colon-cancer chemoprevention (Q34569922) (← links)
- Natural ligands of PPARgamma: are prostaglandin J(2) derivatives really playing the part? (Q34602968) (← links)
- Peroxisome proliferator-activated receptors and cancer: challenges and opportunities (Q35210023) (← links)
- Peroxisome proliferator-activated receptor γ (PPARγ) ligands as bifunctional regulators of cell proliferation (Q35557575) (← links)
- Cancer chemopreventive ability of conjugated linolenic acids (Q35600117) (← links)
- 1. Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands and their therapeutic utility (Q35683565) (← links)
- Peroxisome proliferator activated receptor γ protein expression is asymmetrically distributed in primary lung tumor and metastatic to lung osteosarcoma samples and does not correlate with gene methylation. (Q35763145) (← links)
- Troglitazone and liver injury: in search of answers (Q36013357) (← links)
- Morusin suppresses breast cancer cell growth in vitro and in vivo through C/EBPβ and PPARγ mediated lipoapoptosis (Q36252606) (← links)
- Effects of PPARγ agonistrosiglitazone on human retinoblastoma cell in vitro and in vivo (Q36375151) (← links)
- Non-steroidal anti-inflammatory drugs in prevention of gastric cancer (Q36485784) (← links)
- Targeted elimination of peroxisome proliferator-activated receptor gamma in beta cells leads to abnormalities in islet mass without compromising glucose homeostasis (Q36549465) (← links)
- PPARgamma and Apoptosis in Cancer (Q36742811) (← links)
- Characterization of PPAR dual ligand MCC-555 in AOM-induced colorectal tumorigenesis. (Q36816322) (← links)
- PPARgamma: The Portrait of a Target Ally to Cancer Chemopreventive Agents (Q36859555) (← links)
- Increasing doxorubicin activity against breast cancer cells using PPARγ-ligands and by exploiting circadian rhythms (Q36965932) (← links)
- Thiazolidinediones as anti-cancer agents (Q37010188) (← links)
- Clinical Use of PPARgamma Ligands in Cancer (Q37021288) (← links)
- Basic evidence of molecular targeted therapy for oral cancer and salivary gland cancer (Q37144740) (← links)
- PPAR Ligands for Cancer Chemoprevention (Q37165190) (← links)
- The Critical Role of PPARgamma in Human Malignant Melanoma (Q37165194) (← links)
- Troglitazone Enhances the Apoptotic Response of DLD-1 Colon Cancer Cells to Photodynamic Therapy (Q37231914) (← links)
- Combined low doses of PPARgamma and RXR ligands trigger an intrinsic apoptotic pathway in human breast cancer cells. (Q37316564) (← links)
- Rosiglitazone prevents the progression of preinvasive lung cancer in a murine model (Q37472163) (← links)
- The target of arachidonic acid pathway is a new anticancer strategy for human prostate cancer (Q37586958) (← links)
- Biological Rationale for the Use of PPARγ Agonists in Glioblastoma (Q37636459) (← links)
- PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis. (Q37656960) (← links)
- PPAR Agonists for the Prevention and Treatment of Lung Cancer (Q37681630) (← links)
- Mechanisms by which thiazolidinediones induce anti-cancer effects in cancers in digestive organs. (Q37786227) (← links)
- Relationship between arachidonic acid pathway and human renal cell carcinoma (Q37815383) (← links)